CET and skills guides

Study and gain CET points through OT’s online CET exams, and access archived CET, CPD articles and skills guides in our education library

Find out more

Science and vision

News and features about the latest scientific developments and advances in optometry, ophthalmology and eye medicine

Find out more

Professional support

News and features about the latest developments relating to professional support from across optics. This includes updates from optical organisations such as the AOP and the GOC

Find out more

In practice

News and in-depth features about business management and career development in optics

Find out more


Explore the latest UK and global jobs in the optical sector for optometrists, dispensing opticians and more

Find out more

CooperVision to launch Biofinity toric multifocal contact lenses

The new product is set to be released in April, aiming to help eye care professionals meet the needs of toric wearers as they become presbyopic

CooperVision has revealed plans to launch new Biofinity toric multifocal contact lenses in the UK and Ireland from April.

The company suggested that the new product could help eye care professionals “to keep wearers who are astigmatic in contact lenses as they become presbyopic.”

The new contact lens product combines the optical designs of CooperVision’s Biofinity toric and Biofinity multifocal products.

Krupa Patel, CooperVision’s head of professional services in the UK, said: “Biofinity toric multifocal extends the reliable performance of our Biofinity toric lenses to presbyopic patients.

“Practitioners throughout the UK and Ireland will soon have an easy-to-fit, familiar lens design they can count on to help keep toric wearers satisfied in contact lenses as they age into presbyopia,” Ms Patel added.

The company suggested the Biofinity toric multifocal has a 93% success rate on initial fitting (according to CVI Data), and more than 200,000 unique prescription options.

“Biofinity toric multifocal will soon be a valuable tool for addressing patients’ evolving vision needs,” Ms Patel added.

The lenses recently received CE marking in Europe, as well as approval from the US Food and Drug Administration.

The company confirmed that lens parameters and further product details will be made public in the coming months.